A carregar...
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer
SIMPLE SUMMARY: Although immune-stimulatory and targeted therapies benefit many patients with metastatic kidney cancer, a sizeable proportion of patients fail to respond. Recent studies in mice demonstrate that nutrient-limiting dietary interventions can improve responses to chemotherapy. However, t...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601245/ https://ncbi.nlm.nih.gov/pubmed/33036247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102872 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|